Advinus Therapeutics plans to bring in PE funds to fuel expansion

The flood gates are opening up for Advinus Therapeutics, a Tata Group company in pharma research and development, which is now exploring the possibility of roping in private equity investors to help raise Rs 200-300 crore for its drug development plans.

Related Videos